
|Articles|September 1, 2001
- Applied Clinical Trials-09-01-2001
A New Challange for Central Laboratories
EN ISO/IEC 17025 is more evidence that international standards are evolving to keep pace with technology and improve the performance of accredited central laboratories.
Advertisement
Articles in this issue
almost 25 years ago
Connecting at the Connectathonalmost 25 years ago
Patient Demands vs. Product Developmentalmost 25 years ago
EU Proposes Authorization Changesalmost 25 years ago
FDA Warning Lettersalmost 25 years ago
The Clinical Audit in Pharmaceutical Developmentalmost 25 years ago
What a Form 483 Really Meansalmost 25 years ago
Effective Invvestigator Meetingsalmost 25 years ago
Randomized Controlled Trialsalmost 25 years ago
Domenico Criscuoloalmost 25 years ago
Monitoring Where Others Take HolidaysAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
2
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
3
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5




